A West Dunbartonshire nurse, who found herself in the limelight when she vaccinated the First Minister, has been reflecting on her pandemic experience.
The day job normally for Elaine Anderson (51) is vaccinating school pupils against diseases such as tetanus, diphtheria and polio, but since January she’s been at the forefront of the Covid vaccination programme.
Elaine, from Clydebank, said: “Early on it was recognised that the School Immunisation teams had a great deal of experience in this area and as the schools were closed, we were brought into the Covid vaccination programme.
“It’s been an absolute honour, really quite overwhelming actually. In the beginning, people were coming in, often it was the first time they had been out of the house in months. Some were in tears, there was such relief.
“There’s been a real sense of solidarity – we are in this Covid war together and we will beat it.
“I have met so any great people from so many walks of life. Everyone has a story. So many interesting people I would never normally meet. Now we are vaccinating the young people which is fabulous. Many just say please get it into me – they just want go get back to normality.”
In April, Elaine found herself in front of the cameras when she gave the First Minister her first vaccination – the day Nicola Sturgeon referred to vaccinators as “heroes”.
Elaine said: “It was another honour. She was lovely and quite emotional. My son was very impressed and was telling all his friends his mum is famous as she vaccinated Nicola! Nicola, not even the First Minister!
“Nothing makes me happier than looking out the window and seeing people in their droves, lining up to get their vaccination. There’s such excitement; I get a real buzz. My parting line to them is please don’t have a vaccination party!”
Blackhall Mosque, 1 House O’Hill Road, EH4 2AJ from Monday 9 August to Thursday 12 August and Saturday 14 August from 9.30am to 5.30pm, Sunday 15 August 9.30am to 5pm
Wester Hailes Healthy Living Centre, 30 Harvesters Way, EH14 3JF from Monday 9 August to Sunday 15 August, 9.30am to 5.30pm (5pm on Sunday)
VACCINATION BUS ARRIVES AT NORTH EDINBURGH ARTS TOMORROW
Drop-in clinics will begin to offer Pfizer vaccines to 16 and 17 year olds this weekend, Health Secretary Humza Yousaf confirmed yesterday.
The Scottish Government has written to health boards to say that this age group can now be vaccinated in drop-ins, provided staff training and information resources are in place. Availability will be advertised locally before the full national roll-out on Tuesday.
Anyone in this age group who lives in mainland Scotland can also book an appointment via the online portal at NHS Inform. Eligible young people in Shetland, Orkney and Western Isles will be contacted by their health board and invited to attend clinics.
Health Secretary Humza Yousaf said: “In line with the latest advice from the Joint Committee on Vaccination and Immunisation (JCVI), those who are 16 and 17 will be offered a first dose of the Pfizer-BioNTech vaccine.
“We know that drop-in clinics make it easier for young people to fit getting vaccinated into their busy lives. I am therefore pleased to announce that some clinics will be able to start to offer 16-17 year olds the Pfizer vaccine this weekend. Arrangements differ across the country, and you should check your local health board’s social media channels to see what is available in your local area.
“Then, from Tuesday 10 August, all drop-in clinics in Scotland that offer the Pfizer vaccine will be open to 16-17-year-olds.
“I would urge all eligible young people to take up the offer of vaccination. You can find out where your nearest drop-in clinics are by visiting NHS Inform which will direct you to the latest information from your local health board – or through your local board’s social media channels.
“Our route out of this pandemic is getting as many people vaccinated as quickly as possible, that is why I am urging young people to take up the offer of the vaccine by dropping into a clinic or by booking an appointment.”
All young people 16 to 17 years of age will now be offered the coronavirus (COVID-19) vaccination in Scotland.
In line with the latest advice from the Joint Committee on Vaccination and Immunisation (JCVI), they will be offered a first dose of the Pfizer-BioNTech vaccine.
From Friday (6 August), people who are 16 or 17 in mainland Scotland will be invited to register their interest through the online portal at NHS Inform, and will then be sent an appointment via SMS or email.
Eligible young people in Shetland, Orkney and Western Isles will be contacted by their health board and invited to attend clinics.
Alternatively, drop-in clinics will be available for 16 to 17-years-olds. The start date for clinics opening for this age group will be confirmed shortly.
Anyone who doesn’t register an interest or attend a drop-in clinic, once open, will be sent an appointment invitation through the post. It is expected that everyone in this age group will have been offered a vaccination appointment by the end of September.
Chief Medical Officer Dr Gregor Smith said: “In line with the latest JCVI advice we will now be offering a first dose of the COVID-19 vaccination to young people aged between 16 and 17.
“The programme has always carefully assessed all the benefits and potential risks and offered vaccine to groups where this benefit is clear. The research and evidence shows that is the case for this age group and they should now be called forward for an appointment for a COVID-19 vaccine.
“We will continue to follow the expert JCVI advice and will await the outcome of analysis of data on second doses for this age group and any additional future advice on vaccination for those in the 12-15 age group.”
Health Secretary Humza Yousaf said: “Getting vaccinated has never been easier and from Friday, 16 and 17-year-olds in mainland Scotland will be able to book an appointment through the online portal. We know drop-in clinics are a convenient way for young people to get vaccinated and will announce shortly when these clinics will be open for this age group.
“Vaccination continues to be the best way to protect yourself and those around you and I urge anyone who is eligible to take up the offer of the vaccine.
“The national vaccination programme has been a huge success and without doubt, represents our best way out of the pandemic.”
Background
In addition to 16 to 17-year-olds, we have started offering COVID-19 vaccinations to children and young people who are from key groups; and are between 12 to 17 years. Vaccinations will be offered to:
12 to 15-year-olds with severe neuro-disabilities
12 to 15-year-olds with Down’s syndrome
12 to 15-year-olds with underlying conditions resulting in immunosuppression
12 to 15-year-olds with profound and multiple learning disabilities (PMLD)
12 to 15-year-olds with severe learning disabilities
12 to 17-year-olds who have a diagnosed learning/intellectual disability (mild or moderate)
16-year-olds who have any of these above conditions or underlying conditions that place them at higher risk of serious COVID-19 (that were not 16 at the time of the previous invite for all 16 and 17-year-olds in March 2021)
young people aged 12 years and above who live in the same household of persons (adults or children) who are immunosuppressed (we previously invited over 16s who are household contacts of those on the shielding list)
England, Wales and Northern Ireland will also be taking the JCVI advice.
Health and Social Care Secretary Sajid Javid said: Today’s advice from the independent Joint Committee on Vaccination and Immunisation (JCVI) means more young people aged 16 and over can benefit from COVID-19 vaccines.I have accepted their expert recommendations and I have asked the NHS to prepare to vaccinate those eligible as soon as possible.
“The JCVI have not recommended vaccinating under-16s without underlying health conditions but will keep its position under review based on the latest data.
“Those aged 12 to 15 with severe neuro-disabilities, Down’s Syndrome, immunosuppression and multiple or severe learning disabilities, as well as people in this age group who are household contacts of individuals who are immunosuppressed, are already eligible for vaccination.
“JCVI will continue to review data and provide updates on at risk groups aged 12 to 15 and whether any additional groups will be added.
“COVID-19 vaccines have saved more than 60,000 lives and prevented 22 million infections in England alone. They are building a wall of defence against the virus and are the best way to protect people from serious illness. I encourage everyone who is eligible to come forward for both their jabs as quickly as possible.”
New government-funded clinical trial investigating best COVID-19 vaccine dose interval for pregnant women launched in England
Research shows pregnant women more likely to become seriously ill from COVID-19 and 98% of those in hospital due to COVID-19 are unvaccinated
The UK’s largest clinical trial investigating the best gap between first and second COVID-19 vaccine doses for pregnant women is being launched in England today (Tuesday 3 August).
Following 130,000 pregnant women being vaccinated in the US and no safety concerns being raised, the Pfizer/BioNTech and Moderna vaccines were recommended by the independent experts at the Joint Committee on Vaccination and Immunisation (JCVI) for pregnant women in the UK.
Almost 52,000 pregnant women in England have now been vaccinated – again, with no safety concerns reported.
Data published last week by NHS England and the University of Oxford also shows no pregnant women who have had both doses of a vaccine have been admitted to hospital with COVID-19. Only three have been admitted after having their first dose, meaning 98% of those admitted to hospital have not received a jab.
The Preg-CoV study, backed by £7.5 million of government funding and led by St George’s, University of London, will provide vital clinical trial data on the immune response to vaccination at different dose intervals – either four to six weeks or eight to 12 weeks.
This data will help determine the best dosage interval and tell us more about how the vaccine works to protect pregnant mothers and their babies against COVID-19.
Minister for COVID-19 Vaccine Deployment Nadhim Zahawi said: “Pregnant women are more likely to get seriously ill from COVID-19 and we know that vaccines are safe for them and make a huge difference – in fact no pregnant woman with two jabs has required hospitalisation with COVID-19.
“This government-backed trial will provide more data about how we can best protect pregnant women and their babies, and we can use this evidence to inform future vaccination programmes. I encourage anyone who is pregnant and eligible to sign-up and contribute to research that will save lives for years to come.”
Vaccines have been given to pregnant women to protect them and their babies from diseases for years – including for whooping cough and flu.
The trial will involve over 600 pregnant women being vaccinated with either the Pfizer/BioNTech or the Moderna vaccine. They will be closely monitored by health professionals throughout their pregnancy and following the birth, with the safety of the women taking part in the trial the utmost priority.
The Preg-CoV participants will need to be between 18 and 44 years old, have no health conditions and be between 13 and 34 weeks pregnant on the day of vaccination. They will receive two doses of a COVID-19 vaccine – or one dose if they’ve already had their first – at either the shorter interval of four to six weeks, or the longer interval of eight to 12 weeks.
They will be scheduled to attend nine visits in total and will be required to complete an electronic diary between visits on any symptoms. They will also be given a 24-hour mobile number so they can contact one of the trial team at any time if they have concerns.
The scientists behind the trial will analyse blood samples from the participants and one blood sample from their newborn babies, alongside samples from breastmilk. They will use the samples to help understand more about how the vaccines are protecting these individuals from COVID-19, with initial results expected by the end of the year.
The study will open for applications from volunteers today via the study’s website, with vaccinations set to start from mid-August. Participants will also be recruited to the study by invites sent through the NHS COVID-19 Vaccine Research Registry, which allows research teams to speak to suitable volunteers who have signed up to be contacted about taking part in vaccine studies.
Chief Investigator and Professor of Paediatric Infectious Diseases at St George’s, University of London, Professor Paul Heath said: “Tens of thousands of pregnant women have now been vaccinated in both the US and the UK with no safety concerns reported, but we still lack robust, prospective clinical trial data on COVID-19 vaccines in pregnant women. This includes the best schedule to use to maximally protect them against COVID-19.
“We are extremely pleased to commence the Preg-CoV trial, which aims to fill these gaps in our knowledge and will ultimately inform policy recommendations on the optimal use of COVID-19 vaccines in pregnancy.
The trial will be run across 13 National Institute for Health Research (NIHR) sites in England – including in London, Liverpool and Leeds. All the trial sites are working on ways of including participants from a wide variety of backgrounds and individuals from ethnic minorities are encouraged to apply.
The vaccination programme continues its phenomenal progress towards vaccinating the adult population of the UK, with over 85,336,436 vaccines administered in total – 46,872,411 first doses (88.6%) and 38,464,025 second doses (72.7%).
Further analysis from PHE and the University of Cambridge also suggests vaccines have so far prevented over 52,600 hospitalisations, an estimated 22 million infections and more than 60,000 deaths in England alone.
Dr Pat O’Brien, Vice President of the Royal College of Obstetricians and Gynaecologists, said: “We now have robust data of nearly 200,000 women from across the US and the UK, who have received the COVID-19 vaccine with no safety concerns.
“This tells us that both the Moderna and Pfizer vaccines are safe in pregnancy. However, more research is needed to monitor and understand how pregnant women respond to the COVID-19 vaccine.
“We welcome this trial as the next step in further monitoring the protection provided by the vaccine, to understand the risk of any potential adverse side effects, and observe the immune response within those who are pregnant and their babies.
“We encourage all pregnant women to get vaccinated, as the protection that it provides against COVID-19 to both mother and baby outweigh the risks. We are seeing more pregnant women being admitted to hospital with COVID-19, and we know that the Delta variant is causing more pregnant women to have severe illness than previous strains of the virus.
“We hope that this research will help to gain the confidence of pregnant women that the recommendation of vaccination in pregnancy is based on robust evidence.”
Professor Nick Lemoine, Medical Director, NIHR Clinical Research Network, said: “The fact that every participant in this study receives an approved vaccine will give volunteers peace of mind that they are protected from the virus and that they can take confidence in the safety of these vaccines, and the monitoring involved in the study.
“Vaccine studies like this remain crucial for researchers to gain more information on the best intervals and methods to help protect the whole population against COVID-19.
“It is thanks to the continued dedication and commitment of volunteers that we are at this stage of research and the NIHR is very grateful for their efforts.
“The NHS COVID-19 Vaccine Research Registry continues to help us reach out to potential participants and recruit to additional studies as we keep moving forward, and we encourage interested members of the public to sign up to be contacted at nhs.uk/ResearchContact.”
Over 88% of adults have had a first dose and over 72% of adults have had both doses
Two doses provide over 90% protection against hospitalisation from the Delta variant, which is the dominant strain in the UK
All adults are eligible to get their second dose after eight weeks
More than 85 million doses of a COVID-19 vaccine have been administered across the UK, the latest figures show, as the UK government continues to urge everyone eligible to get their vaccines as soon as possible to protect themselves and their loved ones.
A total of 85,196,986 doses have been administered in the UK, with 46,851,145 people receiving a first dose (88.6%) and 38,345,841 people receiving both doses (72.5%).
The latest data from Public Health England (PHE) and Cambridge University shows that around 60,000 deaths, 22 million infections and 52,600 hospitalisations have been prevented by vaccines up to 23 July.
Health and Social Care Secretary Sajid Javid said: “In under eight months, health services across the UK have delivered more than 85 million doses – this is a phenomenal achievement. It has shown Britain at its best.
“From our NHS administering the jabs, to the armed forces, thousands of volunteers and civil servants, you have all played an important role in getting us to this life-saving milestone – and I want to thank you all for your tireless efforts.
“Please get both of your jabs if you haven’t already to protect yourself and your loved ones.”
Data from PHE shows COVID-19 vaccines are highly effective against hospitalisation from the Delta (B.1.617.2) variant. The analysis shows the Pfizer-BioNTech vaccine is 96% effective and the Oxford-AstraZeneca vaccine is 92% effective against hospitalisation after two doses.
The UK met the Prime Minister’s target ahead of schedule to vaccinate two thirds of adults in the UK with both doses and to offer a first dose to all adults by 19 July.
All adults in the UK are able to get their second doses after eight weeks. This will mean every adult has the chance to have two doses by mid-September.
Vaccines Minister Nadhim Zahawi said: “Our COVID-19 vaccination programme has been an enormous success and has allowed us to cautiously ease restrictions.
“Getting both doses of the vaccine is one of the most important things people can do to help build a wall of defence around yourself, your loved ones and our country.
“I urge everybody to get their jabs so we can carry on doing the things we’ve missed.”
From the end of September, people will be required to prove they’ve had both jabs to enter nightclubs and music events in England.
The UK government announced that people who have been vaccinated with both doses will not have to quarantine on their return to England from an amber list country, providing they received their second jab at least 14 days prior.
From 16 August, double vaccinated people will also no longer be legally required to self-isolate if they are identified as a close contact of a positive COVID-19 case, and will be advised to take a PCR test.
The government announced that double vaccinated frontline NHS and social care staff in England who have been told to self-isolate will be permitted to attend work in exceptional circumstances and replaced by testing mitigations.
A limited number of critical workers may also in exceptional circumstances be able to leave self-isolation to attend work if deemed a close contact and informed to do so by their employer.
The UK government secured access to more than 500 million doses of the most promising COVID-19 vaccines early on behalf of the entire UK, crown dependencies and overseas territories.
The UK’s medicine’s regulator, the MHRA, was the first in the world to approve the Pfizer/BioNTech and Oxford/AstraZeneca vaccines, allowing the rapid deployment of vaccines across the country and ensuring the UK has one of the fastest vaccination programmes in the world.
YouGov polling shows the UK continues to be one of the top nations where people are willing to have a COVID-19 vaccine or have already been vaccinated and ONS data published on 2 July shows that more than 9 in 10 (96%) adults reported positive sentiment towards the vaccine.
Vaccines are available free of charge and from thousands of vaccine centres, GP practices and pharmacies. Around 98% of people live within 10 miles of a vaccination centre in England and vaccinations are taking place at sites including mosques, community centres and football stadiums.
First Minister Nicola Sturgeon will give an update on the latest plans for easing restrictions in Scotland tomorrow.
The latest UK-wide vaccination statistics are published here
The ONS survey on ‘Barriers to COVID-19 vaccination’ can be found here
The YouGov data comparing uptake rates in countries around the world is available here
Children and young people aged 12-17 from key groups to be offered COVID-19 vaccine
Children and young people with certain conditions are to be offered the Pfizer-BioNTech vaccine, in line with the latest advice from the Joint Committee on Vaccination and Immunisation (JCVI), before the majority of schools return on the 16th of August.
The vaccine will be offered to around 4,000 children and young people affected by severe neuro-disabilities, Down’s syndrome, underlying conditions resulting in immunosuppression, and those who have a diagnosis of Learning/Intellectual disability.
In addition, the JCVI recommended vaccinating young people aged 16 to 17 years of age who are at higher risk of serious illness from COVID-19. While the vast majority of this group were previously invited in an earlier part of the vaccination programme we will be inviting those that are now 16 who were not vaccinated as part of that earlier offer.
Also to be invited are children and young people aged 12-17 who are household contacts of adults or children who are immunosuppressed. This is to provide indirect protection for that member of their household. A household contact is defined as someone living in the same house, or anyone the adult or child comes in to contact with face-to-face on most days of the week – such as a carer.
NHS Scotland is aiming to vaccinate these children and young people during August alongside those younger household contacts of people with immunosuppression.
Those children and young people with specific conditions and their parents or carers will be contacted directly by their local Health Boards via letter, phone call or by their regular healthcare professional. The household contacts of the wider group of people with immunosuppression will be contacted by a letter from the National Vaccination Programme.
Health Secretary Humza Yousaf said: “In line with the latest JCVI advice we will now be offering COVID-19 vaccinations to children and young people aged between 12 and 17 from key groups.
“The programme has always offered vaccine to groups where the benefits far outweigh the risks. The research and evidence shows that is the case for young people in these groups and they should now be called forward for a COVID-19 vaccine.
“These children and young people will be able to get the vaccine in the most appropriate setting for their situation. This may be in their own home or a care setting, or at a clinic, depending on their care or health needs.
“I would urge any parent or carer who has a child or young person eligible for a vaccine to visit NHS Inform where they can find the most up-to-date information; and read the leaflet that they will receive with their letter or from their Health Board. Parents, carers or young people can also speak to their local health professional to discuss this further if they need to.”
NHS’ Lothian’s vaccination Lothian Buses vaccination bus is rolling into the Grassmarket again today.
Anyone over 18 who requires either a 1st or 2nd dose of Moderna or AZ (provided they received the 1st more than 8 weeks ago) can attend – no appointment necessary.
NHS Lothian’s pop-up COVID-19 vaccination clinic scheme has seen its most successful day at Gyle Shopping Centre with 330 people attending.
The Gyle Shopping Centre pop-up clinic was launched on Tuesday (27 July) within an outlet at the centre alongside some of the biggest names in retail, allowing for those shopping or working nearby to drop-in to get their life-saving vaccine.
For the first time all three vaccines are available, allowing those in need of a second dose of Pfizer to be vaccinated. Moderna and AstraZeneca are also available at the centre.
The clinic is open to everyone over the age of 18 for their first or second dose, provided there has been an eight week gap between vaccinations.
Pat Wynne, Director of Community Nursing, NHS Lothian, said: “To see these numbers come through our clinic at Gyle is fantastic and it reinforces our decision to use pop-up clinics in order to move forward with our vaccination programme.
“We are really pleased to have teamed up with Gyle Shopping Centre and we are grateful to them for providing this space for such a prominent drop-in clinic and supporting our team with queue management.
“Sites like Gyle Shopping Centre are great venues for us because they allow people to easily drop in when they are out shopping or taking a break from work. I would encourage anyone who is due to be vaccinated to consider coming to our Gyle clinic as soon as possible.”
The Gyle pop-up clinic will run until Saturday 14 August and is open every day between 10am to 6pm.
Mr Wynne added: “Pop-up clinics are part of the campaign to target younger people and make it as easy as possible for them to get the vaccine in the places they visit.
“We feel the clinic at Gyle will also help us target people between the ages of 18-29, who we especially need to come forward for vaccination. We remain determined to do everything we can to make sure as many people are vaccinated as possible.”
NHS Lothian’s vaccination bus, which is being run along with Lothian Buses, is continuing to visit sites across Lothian. More details on its locations can be found in the COVID vaccination hub on NHS Lothian’s website.
